Amgen

finch canary cage free bird release
Biotech

FDA lifts hold on Amgen's phase 1 obesity study

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling participants.
Gabrielle Masson May 2, 2025 10:10am
Abstract modern white spiral clock dial with roman and arabic numerals

Lilly links lepodisiran to durably lower lipoprotein in phase 2

Mar 31, 2025 4:24am
rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am
chop down cut tree chainsaw ax

Amgen, CytomX ax T-cell engager after assessing data, priorities

Mar 7, 2025 5:39am
boat cutting through water

Amgen’s late-stage obesity trials expected to read out in ‘27

Mar 5, 2025 1:58pm
cancel

Amgen and Ideaya ax cancer combination trial

Feb 13, 2025 7:34am